Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Ronde

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Intervirology|January 1, 1987
The early enhancer-promoter of BKV and host range for transformationA de Ronde, M MacDonald, C Sol, et al.
Virology|September 1, 1992
Modulation of the human papillomavirus type 16 induced transformation and transcription by deletion of loci on the short arm of human chromosome 11 can be mimicked by SV40 small tP H Smits, A de Ronde, H L Smits, et al.
Lancet (London, England)|September 3, 1988
Seroconversion to HIV-1 negative regulation factorA de Ronde, P Reiss, J Dekker, et al.
European Journal of Biochemistry|October 3, 1983
Biosynthesis of the ubiquinol-cytochrome c reductase complex in yeast. Characterization of precursor forms of the 44-kDa, 40-kDa and 17-kDa subunits and identification of individual messenger RNAs for these and other imported subunits of the complexA P Van Loon, J Kreike, A De Ronde, et al.
The Journal of General Virology|April 1, 1994
Monoclonal antibodies to immunodominant and neutralizing domains of the envelope surface protein of feline immunodeficiency virusH Egberink, L Keldermans, N Schuurman, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individualsP Reiss, J M Lange, A de Ronde, et al.
Vaccine|April 1, 1996
Suppression of virus burden by immunization with feline immunodeficiency virus Env proteinM J Hosie, T H Dunsford, A de Ronde, et al.
AIDS Research and Human Retroviruses|December 1, 1989
Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progressionP Reiss, A De Ronde, J M Lange, et al.
AIDS Research and Human Retroviruses|October 6, 2000
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivoM P de Baar, W Janssens, A de Ronde, et al.
Journal of Clinical Microbiology|April 3, 2001
Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and OM P de Baar, M W van Dooren, E de Rooij, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Intervirology|January 1, 1987
The early enhancer-promoter of BKV and host range for transformationA de Ronde, M MacDonald, C Sol, et al.
Virology|September 1, 1992
Modulation of the human papillomavirus type 16 induced transformation and transcription by deletion of loci on the short arm of human chromosome 11 can be mimicked by SV40 small tP H Smits, A de Ronde, H L Smits, et al.
Lancet (London, England)|September 3, 1988
Seroconversion to HIV-1 negative regulation factorA de Ronde, P Reiss, J Dekker, et al.
European Journal of Biochemistry|October 3, 1983
Biosynthesis of the ubiquinol-cytochrome c reductase complex in yeast. Characterization of precursor forms of the 44-kDa, 40-kDa and 17-kDa subunits and identification of individual messenger RNAs for these and other imported subunits of the complexA P Van Loon, J Kreike, A De Ronde, et al.
The Journal of General Virology|April 1, 1994
Monoclonal antibodies to immunodominant and neutralizing domains of the envelope surface protein of feline immunodeficiency virusH Egberink, L Keldermans, N Schuurman, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individualsP Reiss, J M Lange, A de Ronde, et al.
Vaccine|April 1, 1996
Suppression of virus burden by immunization with feline immunodeficiency virus Env proteinM J Hosie, T H Dunsford, A de Ronde, et al.
AIDS Research and Human Retroviruses|December 1, 1989
Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progressionP Reiss, A De Ronde, J M Lange, et al.
AIDS Research and Human Retroviruses|October 6, 2000
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivoM P de Baar, W Janssens, A de Ronde, et al.
Journal of Clinical Microbiology|April 3, 2001
Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and OM P de Baar, M W van Dooren, E de Rooij, et al.
Pageof 7